Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.590
-0.009 (-1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
0.590
0.00 (0.00%)
Pre-market: Apr 29, 2026, 8:11 AM EDT
Kairos Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -5.45 | -2.6 | -1.81 | -1.05 | -2.15 | |
| Depreciation & Amortization | 0.16 | 0.16 | 0.16 | 0.16 | 0.1 | |
| Other Amortization | - | 0.15 | 0.06 | 0.41 | 0.14 | |
| Stock-Based Compensation | 0.48 | 0.22 | - | - | 0.3 | |
| Other Operating Activities | 2.17 | 0.1 | 0.91 | - | - | |
| Change in Accounts Payable | -0.79 | 0.4 | 0.77 | 0.13 | 1.19 | |
| Change in Other Net Operating Assets | -0.01 | -2.39 | -0.01 | - | - | |
| Operating Cash Flow | -3.44 | -3.96 | 0.08 | -0.35 | -0.41 | |
| Cash Acquisitions | - | - | - | - | -0.11 | |
| Investing Cash Flow | - | - | - | - | -0.11 | |
| Short-Term Debt Issued | - | 0.14 | - | - | - | |
| Long-Term Debt Issued | 3.6 | - | - | 0.93 | 0.35 | |
| Total Debt Issued | 3.6 | 0.14 | - | 0.93 | 0.35 | |
| Short-Term Debt Repaid | - | -0.14 | - | -0.04 | -0.02 | |
| Total Debt Repaid | - | -0.14 | - | -0.04 | -0.02 | |
| Net Debt Issued (Repaid) | 3.6 | - | - | 0.89 | 0.33 | |
| Issuance of Common Stock | - | 5.52 | - | - | 0.25 | |
| Other Financing Activities | 3.06 | -0.39 | -0.43 | -0.17 | - | |
| Financing Cash Flow | 6.66 | 5.13 | -0.43 | 0.72 | 0.58 | |
| Net Cash Flow | 3.22 | 1.18 | -0.34 | 0.36 | 0.06 | |
| Cash Interest Paid | - | 0 | - | - | - | |
| Levered Free Cash Flow | -1.63 | -5.35 | 0.76 | 0.01 | 0.47 | |
| Unlevered Free Cash Flow | -1.63 | -5.38 | 0.77 | -0.12 | 0.42 | |
| Change in Working Capital | -0.81 | -1.98 | 0.76 | 0.13 | 1.19 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.